Commission Regulation (EC) No 1533/2000 of 13 July 2000 amending Regulation (EC) No 1485/96 laying down detailed rules for the application of Council Directive 92/109/EEC, as regards customer declarations of specific use relating to certain substances used in the illicit manufacture of narcotic drugs and psychotropic substances (Text with EEA relevance)
Date: 2000-07-13
Institutions: European Commission
Subjects: administrative cooperation, chemical product, customs document, marketing, narcotic, psychotropic substance

14.7.2000

EN

Official Journal of the European Communities

L 175/75

COMMISSION REGULATION (EC) No 1533/2000

of 13 July 2000

amending Regulation (EC) No 1485/96 laying down detailed rules for the application of Council
Directive 92/109/EEC, as regards customer declarations of specific use relating to certain substances
used in the illicit manufacture of narcotic drugs and psychotropic substances

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

(4)

Having regard to the Treaty establishing the European
Community,

Having regard to Council Directive 92/109/EEC of 14
December 1992 on the manufacture and the placing on the
market of certain substances used in the illicit manufacture of
narcotic drugs and psychotropic substances (1), as amended by
Commission Directive 93/46/EEC (2), and in particular Article
10 thereof,

Whereas:

(1)

(2)

(3)

Commission Regulation (EC) No 1485/96 of 26 July
1996 laying down detailed rules for the application of
regards customer
Council Directive 92/109/EEC, as
declarations of specific use relating to certain substances
used in the illicit manufacture of narcotic drugs and
psychotropic substances (3) provides for model declara-
tions of use for individual and multiple transactions.

In view of the difficulties caused by the use, by opera-
tors, of non-harmonised models and the use of all the
official languages of the Community, it is necessary to
draw up a uniform model for all operators to facilitate
monitoring of the declarations by the Member State
authorities.

Although most competent authorities issue approvals of
limited duration, this limit is not indicated in the model
set out in the Annex to the Regulation, with the result
that an undertaking, acting in good faith, could supply
category 1 or category 2 substances to an undertaking
for which authorisation has expired.
is therefore
necessary to indicate any expiry date on the model
declarations.

It

The provisions of this Regulation are in accordance with
the opinion of the Committee set up under Article 10 of
Council Regulation (EEC) No 3677/90 of 13 December
1990 laying down measures to be taken to discourage
the diversion of certain substances to the illicit manufac-
ture of narcotic drugs and psychotropic substances (4), as
last amended by Commission Regulation (EEC) No
3769/92 of 21 December 1992 (5) and as referred to in
Directive 92/109/EEC,

HAS ADOPTED THIS REGULATION:

Article 1

Regulation (EC) No 1485/96 is hereby amended as follows:

1. The second paragraph of Article 1 is replaced by the

following text:

‘2.
The declaration shall conform to the model set out in
point 1 of the Annex to this Regulation. In the case of legal
persons, the declaration shall be made on headed note-
paper.’

2. The second paragraph of Article 2 is replaced by the

following text:

The declaration shall conform to the model set out in
‘2.
point 2 of the Annex to this Regulation. In the case of legal
persons, the declaration shall be made on headed note-
paper.’

3. The Annex is replaced by the Annex hereto.

Article 2

This Regulation shall enter into force on the twentieth day
following that of its publication in the Official Journal of the
European Communities.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 13 July 2000.

For the Commission

Erkki LIIKANEN

Member of the Commission

(1) OJ L 370, 19.12.1992, p. 76.
(2) OJ L 159, 1.7.1993, p. 134.
(3) OJ L 188, 27.7.1996, p. 28.

(4) OJ L 357, 20.12.1990, p. 1.
(5) OJ L 383, 29.12.1992, p. 17.

L 175/76

EN

Official Journal of the European Communities

14.7.2000

1. Model declaration relating to individual transactions (category 1 or 2)

ANNEX

CUSTOMER DECLARATION OF SPECIFIC USE(S) OF THE SCHEDULED CATEGORY 1 OR 2 SUBSTANCE

(INDIVIDUAL TRANSACTIONS)

I/We,

Name . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Address . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Authorisation/Licence/Registration No or reference (1)

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

issued on . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . by . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(name and address of the authority)

and valid until/without time limit (complete as appropriate)

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

have ordered from:

Name . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Address . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

the following substance: (name and CN code) (2)

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(quantity) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

the substance will be used solely for . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

We confirm that the substance referred to above will only be re-sold or otherwise supplied to a customer on
the condition that the customer will furnish a declaration of use in accordance with this model or, for category
2 substances, a declaration relating to multiple transactions.

Signature . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Name . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . .

(in block capitals)

Position . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Date . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(1) Complete as appropriate.
(2) Combined Nomenclature code.

14.7.2000

EN

Official Journal of the European Communities

L 175/77

2. Model declaration relating to multiple transactions (category 2)

CUSTOMER DECLARATION OF SPECIFIC USE(S) OF THE SCHEDULED CATEGORY 2 SUBSTANCE

(MULTIPLE TRANSACTIONS)

I/We,

Name . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Address . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Registration No or reference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Registered on . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . by . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(name and address of the authority)

and valid until/without time limit (complete as appropriate)

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

intend to order from:

Name . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Address . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

the following substance: (name and CN code) (1)

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(quantity) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

the substance will be used solely for . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

and represents a supply which on best estimate will be sufficient for ............ months (maximum of 12 months).

We confirm that the substance referred to above will only be re-sold or otherwise supplied to a customer on
the condition that the customer will furnish a declaration of use in accordance with this model or a declaration
relating to individual transactions.

Signature . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Name . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . .

(in block capitals)

Position . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Date . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(1) Combined Nomenclature code.